Keytruda is generically known as PEMBROLIZUMAB. Immunotherapy X thanks to its action in the body that the drug is used to treat cancer. The drug is prepared and enters the body by intravenous injection.

When cancer begins in one part of the body and spreads to another, it is called metastasis. Brain metastases are when primary lung cancer has produced one or more secondary tumors in the brain.

Positive treatment results when using the immunotherapy drug Pembrolizumab (Keytruda) are encouraging signs for cancer patients, especially those with late-stage, metastatic cancer.

Pembrolizumab (Keytruda) is one of a number of immunosuppressive cancer drugs. The following article briefly presents the results of a newly published study of Pembrolizumab (Keytruda) for advanced gastric and esophageal cancer.